A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission fromvaccinees to mosquitoes
Jm. Troyer et al., A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission fromvaccinees to mosquitoes, AM J TROP M, 65(5), 2001, pp. 414-419
Citations number
34
Categorie Soggetti
Envirnomentale Medicine & Public Health","Medical Research General Topics
2A Delta 30 is a live dengue-4 virus vaccine candidate with a 30-nucleotide
deletion in its 3'-untranslated region. To assess the transmissibility of
2A Delta 30 by mosquitoes, we compared its in vivo replication in mosquitoe
s with that of its wild type DEN-4 parent. Both the vaccine candidate and w
ild type virus were equally able to infect the mosquito Toxorhynchites sple
ndens after intrathoracic inoculation. Relative to its wild type parent, 2A
Delta 30 was slightly restricted in its ability to infect the midgut of Ae
des aegypti mosquitoes fed on an artificial blood meal and was even more re
stricted in its ability to disseminate from the midgut to the salivary glan
ds. Thus, the 30-nucleotide deletion rendered the vaccine candidate more se
nsitive than its wild type parent to the mosquito rnidgut escape barrier. M
ost significantly, 2A Delta 30 was not transmitted to 352 Ae. albopictus mo
squitoes fed on 10 vaccinees. all of whom were infected with the vaccine ca
ndidate.